XML 19 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCKHOLDERS' EQUITY (Details) (USD $)
9 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
$ 4.00-$13.99 [Member]
Sep. 30, 2012
$ 14.00-$19.99 [Member]
Sep. 30, 2012
$ 20.00-$25.00 [Member]
Sep. 30, 2012
Performance-based shares [Member]
Sep. 30, 2012
Restricted Stock [Member]
Sep. 30, 2011
Restricted Stock [Member]
Sep. 30, 2012
Restricted Stock [Member]
Sep. 30, 2011
Restricted Stock [Member]
Dec. 31, 2011
Restricted Stock [Member]
Sep. 30, 2012
Stock Options [Member]
Sep. 30, 2011
Stock Options [Member]
Dec. 31, 2011
Stock Options [Member]
Restricted Stock [Abstract]                            
Number of stock incentive plans 2                          
Vesting period of performance-based shares           4 years                
Specified operating income margin period           one or more of the fiscal years                
Net share settlement for restricted stock (in shares)                 24,488          
Net share settlement for stock options (in shares)                         24,527  
Decrease in equity due to payment of tax for employee $ 200,000 $ 400,000                        
Shares                            
Nonvested restricted stock outstanding, beginning balance (in shares)                 501,551          
Restricted stock awarded (in shares)                 190,285          
Restricted stock vested (in shares)                 (102,176)          
Nonvested restricted stock outstanding, ending balance (in shares)             589,660   589,660          
Weighted Average Grant Date Fair Value Per Share                            
Nonvested restricted stock outstanding, beginning balance (in dollars per share)                 $ 16.10          
Restricted stock awarded (in dollars per share)                 $ 7.68          
Restricted stock vested (in dollars per share)                 $ 14.64          
Nonvested restricted stock outstanding, ending balance (in dollars per share)             $ 13.64   $ 13.64          
Recognized restricted stock expense             500,000 500,000 2,300,000 2,500,000        
Unrecognized restricted stock expense             5,800,000   5,800,000   6,800,000      
Aggregate intrinsic value of outstanding restricted shares             2,500,000   2,500,000          
Stock Options [Abstract]                            
Weighted average fair values of options granted (in dollars per share) $ 2.52                          
Weighted average assumptions for grants [Abstract]                            
Expected volatility (in hundredths)                       51.25%    
Expected dividend yield (in hundredths)                       3.59%    
Expected life (term)                       4 years 7 months 24 days    
Risk-free interest rate (in hundredths)                       0.87%    
Weighted-average exercise price during the year (in dollars per share)                       $ 7.79    
Shares                            
Outstanding, beginning balance (in shares)                       533,375    
Granted (in shares)                       157,000    
Canceled (in shares)                       (22,500)    
Exercised (in shares)                       0    
Outstanding, ending balance (in shares)                       667,875   533,375
Vested or expected to vest (in shares)                       632,676    
Exercisable, ending balance (in shares)                       491,881    
Weighted Average Exercise Price Per Share                            
Outstanding, beginning balance (in dollars per share)                       $ 16.60    
Granted (in dollars per share)                       $ 7.79    
Canceled (in dollars per share)                       $ 10.09    
Exercised (in dollars per share)                       $ 0    
Outstanding, ending balance (in dollars per share)                       $ 14.75   $ 16.60
Vested or expected to vest (in dollars per share)                       $ 15.02    
Exercisable, ending balance (in dollars per share)                       $ 16.49    
Weighted Average Remaining Contractual Term                            
Outstanding, beginning balance                       5 years 1 month 10 days   4 years 8 months 5 days
Outstanding, ending balance                       5 years 1 month 10 days   4 years 8 months 5 days
Vested or expected to vest                       4 years 10 months 20 days    
Exercisable, ending balance                       3 years 8 months 8 days    
Aggregate Intrinsic Value                            
Outstanding, beginning balance                       0    
Granted                       0    
Exercised                       0    
Outstanding, ending balance                       0   0
Vested or expected to vest                       0    
Exercisable, ending balance                       0    
Unrecognized pre-tax compensation expense                       $ 400,000    
Weighted average period of unrecognized pre-tax compensation                       2 years 2 months 19 days    
Range of Exercise Prices                            
Range of Exercise Prices, Minimum (in dollars per share)     $ 4.00 $ 14.00 $ 20.00                  
Range of Exercise Prices, Maximum (in dollars per share)     $ 13.99 $ 19.99 $ 25.00                  
Stock Options Outstanding                            
Shares (in shares) 667,875   268,292 277,083 122,500                  
Contractual Weighted Average Life 5 years 1 month 10 days   7 years 3 months 25 days 3 years 5 months 4 days 4 years 0 months 21 days                  
Weighted Average Price (in dollars per share) $ 14.75   $ 9.68 $ 16.42 $ 22.07                  
Stock Options Exercisable                            
Shares (in shares) 491,881   121,292 262,421 108,168                  
Weighted Average Price (in dollars per share) $ 16.49   $ 11.97 $ 16.22 $ 22.23